In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors

Bevington, 2003 Briard, 2008, Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo, J. Med. Chem., 51, 17, 10.1021/jm0707370 Burns, 2007, [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor, Proc. Natl. Acad. Sci. U. S. A., 104, 9800, 10.1073/pnas.0703472104 Donohue, 2008, Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors, J. Med. Chem., 51, 5608, 10.1021/jm800329z Eggan, 2008, Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia, Arch. Gen. Psychiatry, 65, 772, 10.1001/archpsyc.65.7.772 Frost, 1984, Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters, Brain Res., 305, 1, 10.1016/0006-8993(84)91113-2 Gazzerro, 2007, Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population, Int. J. Obes. (Lond)., 31, 908, 10.1038/sj.ijo.0803510 Glass, 1997, Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain, Neuroscience, 77, 299, 10.1016/S0306-4522(96)00428-9 Herkenham, 1990, Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. U. S. A., 87, 1932, 10.1073/pnas.87.5.1932 Innis, 2007, Consensus nomenclature for in vivo imaging of reversibly binding radioligands, J. Cereb. Blood Flow Metab., 27, 1533, 10.1038/sj.jcbfm.9600493 Jenko, 2012, Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia, Schizophr. Res., 141, 185, 10.1016/j.schres.2012.07.021 Jones, 2008, End of the line for cannabinoid receptor 1 as an anti-obesity target?, Nat. Rev. Drug Discov., 7, 961, 10.1038/nrd2775 Katona, 2008, Endocannabinoid signaling as a synaptic circuit breaker in neurological disease, Nat. Med., 14, 923, 10.1038/nm.f.1869 Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0 National Academy Press, 1996 Sanabria-Bohórquez, 2010, Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain, Eur. J. Nucl. Med. Mol. Imaging, 37, 920, 10.1007/s00259-009-1340-5 Terry, 2009, Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand, Neuroimage, 48, 362, 10.1016/j.neuroimage.2009.06.059 Terry, 2010, Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using 18F-labeled inverse agonist radioligands, J. Nucl. Med., 51, 112, 10.2967/jnumed.109.067074 Tzourio-Mazoyer, 2002, Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain, Neuroimage, 15, 273, 10.1006/nimg.2001.0978 Van Gaal, 2005, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, 365, 1389, 10.1016/S0140-6736(05)66374-X Waterhouse, 2003, Determination of lipophilicity and its use as a predictor of blood–brain barrier penetration of molecular imaging agents, Mol. Imaging Biol., 5, 376, 10.1016/j.mibio.2003.09.014 Wilson, 2002, Endocannabinoid signaling in the brain, Science, 296, 678, 10.1126/science.1063545 Wong, 2010, Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR, Neuroimage, 52, 1505, 10.1016/j.neuroimage.2010.04.034 Yasuno, 2002, Template-based method for multiple volumes of interest of human brain PET images, Neuroimage, 16, 577, 10.1006/nimg.2002.1120 Yasuno, 2008, The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain, Neuropsychopharmacology, 33, 259, 10.1038/sj.npp.1301402 Zoghbi, 1997, A radiotracer technique for determining apparent pKa of receptor-binding ligands, J. Label. Compd. Radiopharm., 40SI, 136 Zoghbi, 2006, PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements, J. Nucl. Med., 47, 520 Zoghbi, 2012, On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human, J. Pharm. Sci., 101, 1028, 10.1002/jps.22822